Skip to content

Clinical efficacy of acupuncture combined with embodied mirroring therapy in patients with central facial paralysis after stroke

Clinical efficacy of acupuncture combined with embodied mirroring therapy in patients with central facial paralysis after stroke

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500098296
Enrollment
Unknown
Registered
2025-03-05
Start date
2025-03-10
Completion date
Unknown
Last updated
2025-03-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

stroke

Interventions

control group:basic treatment
mirror group:mirror treatment
acupuncture group:cephalic acupuncture treatment
Mirror Image Combined Acupuncture Groups:cephalic acupuncture combined with mirror therapy

Sponsors

Jing'an District Central Hospital Of Shanghai
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 85 Years

Inclusion criteria

Inclusion criteria: 1. The diagnosis met the diagnostic criteria for stroke in the Diagnostic Points for Various Major Cerebrovascular Diseases in China 2019; the age of the patients was 18 to 85 years old; 2.(2) First stroke; no significant cognitive dysfunction, mini-mental state examination (MMSE) >= 24 points; 3.(3) Unilateral central facial paralysis (facial paralysis below the ophthalmic fissure, such as tilting of the tongue, salivation or drooping of the corners of the mouth, loss or shallowing of the nasolabial folds, and spasticity and twitching of the facial muscles) and/or lesions above the nucleus of the facial nerve on Computed Tomography (CT) and/or Magnetic Resonance Imaging (MRI) after stroke. Imaging (MRI) showing lesions above the facial nerve nucleus; 4.(4) Patients signed an informed consent form to participate in this study voluntarily. (Remarks: If unable to sign due to hand motor dysfunction, handprints or videos were taken as proof of signing the informed consent).

Exclusion criteria

Exclusion criteria: 1. Those whose vital signs are unstable or whose condition continues to progress; 2.(2) Patients with severe cardiovascular, hepatic, renal, and hematopoietic impairments; 3.(3) Patients with peripheral facial paralysis:There is no forehead movement; 4.(4) The presence of abnormalities that prevent cooperation with treatment, such as visual or hearing impairment, attention deficit, and lateralized neglect; 5.(5) Patients participating in other interventional studies during the same period.

Design outcomes

Primary

MeasureTime frame
SFGS;

Secondary

MeasureTime frame
eFACE;FDI;Chinese Medicine Evidence Rating Scale;Distance Angle Measurement;Difference in EMG wave amplitude between affected and healthy side;Efficacy Evaluation Criteria;functionalnear-infraredspectroscopy,fNIRS;functional magnetic resonance (fMR);MMSE;HBGS;

Countries

China

Contacts

Public ContactJie Jia

Shanghai Jing'an District Central Hospital; Huashan Hospital, Fudan University

shannonjj@126.com+86 21 5288 7820

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026